These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12109829)

  • 21. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
    Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.
    Waldron J; Warde P; Irish J; Pintilie M; Sellmann S; Bayley A; Cummings B; Kim J; Liu FF; Payne D; Ringash J; Brown D; Freeman J; Gilbert R; Gullane P; Witterick I; O'Sullivan B
    Radiother Oncol; 2008 May; 87(2):173-80. PubMed ID: 18342965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomas.
    Allal AS; Bieri S; Miralbell R; Marchal F; Lehmann W; Kurtz JM
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):685-9. PubMed ID: 9240633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics--a phase II multicenter study.
    Antognoni P; Bignardi M; Cazzaniga LF; Poli AM; Richetti A; Bossi A; Rampello G; Barbera F; Soatti C; Bardelli D; Giordano M; Danova M
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1137-45. PubMed ID: 8985036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Johnson CR; Schmidt-Ullrich RK; Wazer DE
    Cancer; 1992 Jun; 69(11):2749-54. PubMed ID: 1571905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.
    Kaanders JH; van Daal WA; Hoogenraad WJ; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 1992; 24(3):497-503. PubMed ID: 1399736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG).
    Marcial VA; Pajak TF; Chang C; Tupchong L; Stetz J
    Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):41-7. PubMed ID: 3542916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose, time, and fraction size issues for late effects in head and neck cancers.
    Taylor JM; Mendenhall WM; Lavey RS
    Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
    Bedi M; Firat S; Semenenko VA; Schultz C; Tripp P; Byhardt R; Wang D
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e87-92. PubMed ID: 22516389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report.
    Arias F; Domínguez MA; Illarramendi JJ; Martínez E; Tejedor M; Domínguez S; Dueñas M; Villafranca E; Elcarte F; Miquéliz S
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):675-82. PubMed ID: 7558958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.
    Cox JD; Pajak TF; Marcial VA; Coia L; Mohiuddin M; Fu KK; Selim H; Rubin P; Ortiz H
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1191-5. PubMed ID: 2045293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
    Maciejewski B; Withers HR; Taylor JM; Hliniak A
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.